ArticleFrontiers in neurology
Early multimodal neuromonitoring is associated with outcomes in critically ill patients with hemorrhagic stroke.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05501613 (Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early outcome prediction in critically ill patients with spontaneous intracerebral haemorrhage (ICH) remains challenging. Invasive multimodal neuromonitoring may offer prognostic insights. Methods: We conducted a single-centre retrospective observational study including critically ill ICH patients admitted to the Neurocritical Care Unit between January 2015 and September 2021. Neuromonitoring variables were analysed during the first 48 h and included intracranial pressure (ICP), cerebral perfusion pressure (CPP), pressure reactivity index (PRx), and optimal CPP (CPPopt). Six-month functional outcomes were assessed using the modified Rankin Scale (mRS) score and dichotomized as severe if death or vegetative state (mRS score 5-6) or nonsevere (mRS score 1-4). Results: Among 65 patients with a mean age of 62.6 ± 13.2 years, the mean PRx was significantly higher in patients with a severe outcome (0.27 ± 0.27 vs. 0.12 ± 0.18; Discussion: Although ICP is the most extensively studied neuromonitoring parameter, it may not be the most informative parameter associated with outcome in this population during the early phase. Critically ill patients with ICH who exhibit impaired cerebrovascular reactivity (PRx > 0.2) or lower CPP than CPPopt within the first 48 h were associated with a higher likelihood of poor functional outcomes at 6 months. These findings support the hypothesis that advanced neuromonitoring parameters may provide additional prognostic information beyond mean ICP values in this population. Clinical trial registration: ClinicalTrials.gov, identifier NCT05501613.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.